Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GANfort vs Xalatan in Treatment-Naïve Open-Angle Glaucoma
NCT01243567Phase 4Completed
- Sponsor
- Allergan
- Start
- Jun 2010
- Primary completion
- Feb 2012
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of bimatoprost, timolol in open-angle glaucoma (OAG), sponsored by Allergan. Started Jun 2010; status: completed.
02
Drugs
bimatoprosttimolol
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT01243567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01243567.